Cargando…

Evaluation of the Multiple Sclerosis Spasticity Scale 88: A Short Report

BACKGROUND: The Multiple Sclerosis Spasticity Scale 88 (MSSS-88) is designed to capture the patient experience and impact of spasticity, but there is limited evaluation against clinician-rated measures of spasticity. OBJECTIVE: To evaluate the convergent validity and responsiveness of the MSSS-88. D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freeman, Jenny, Gorst, Terry, Ofori, Jodielin, Marsden, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276976/ https://www.ncbi.nlm.nih.gov/pubmed/34497457 http://dx.doi.org/10.1177/1179572718823510

Ejemplares similares

Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88)
por: Rodic, Sindi Z., et al.
Publicado: (2016)

Linguistic and psychometric validation of the MSSS-88 questionnaire for patients with multiple sclerosis and spasticity in Germany
por: Henze, Thomas, et al.
Publicado: (2014)

Leg Spasticity and Ambulation in Multiple Sclerosis
por: Balantrapu, Swathi, et al.
Publicado: (2014)

Cannabinoids in the management of spasticity associated with multiple sclerosis
por: Malfitano, Anna Maria, et al.
Publicado: (2008)

Dry needling for treating spasticity in multiple sclerosis
por: del Pilar Pérez-Trujillo, María, et al.
Publicado: (2021)

A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols
por: Chisari, Clara Grazia, et al.
Publicado: (2023)

Spasticity, spastic dystonia, and static stretch reflex in hypertonic muscles of patients with multiple sclerosis
por: Puce, Luca, et al.
Publicado: (2021)

Spasticity in multiple sclerosis and role of glatiramer acetate treatment
por: Meca-Lallana, Jose Eustasio, et al.
Publicado: (2015)

Functional intermuscular reduction in spasticity for people with multiple sclerosis
por: Miller, Bobbette J, et al.
Publicado: (2022)

Clinical insights on the spasticity-plus syndrome in multiple sclerosis
por: Alami Marrouni, Kanza, et al.
Publicado: (2022)

The Coexistence of Multiple Sclerosis and Hereditary Spastic Paraparesis in a Patient
por: Yazıcı, Işıl, et al.
Publicado: (2013)

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
por: Patti, F, et al.
Publicado: (2016)

Isolated Trapezius Strain in a Patient with Multiple Sclerosis and Spasticity
por: Wang, Eric C., et al.
Publicado: (2015)

Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis
por: Novarella, Federica, et al.
Publicado: (2022)

88 short stories
por: Maupassant, Guy de, 1850-1893
Publicado: (1958)

88 short stories
por: Maupassant, Guy de, 1850-1893
Publicado: (1950)

The Effect of Repetitive Transcranial Magnetic Stimulation on Spasticity in Patients with Multiple Sclerosis
por: Şan, Ayça Uran, et al.
Publicado: (2019)

New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids
por: Smith, Paul F
Publicado: (2010)

Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation
por: Russo, Margherita, et al.
Publicado: (2015)

Theoretical and Therapeutic Implications of the Spasticity-Plus Syndrome Model in Multiple Sclerosis
por: Bruno, Antonio, et al.
Publicado: (2022)

Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis
por: Zheng, Chao, et al.
Publicado: (2020)

Goal-Setting in Multiple Sclerosis-Related Spasticity Treated with Botulinum Toxin: The GASEPTOX Study
por: Baccouche, Ines, et al.
Publicado: (2022)

Using modified Ashworth scale for assessing multiple sclerosis-associated spasticity: a high time for a paradigm shift
por: MohanaSundaram, ArunSundar, et al.
Publicado: (2023)

Effects of Dry Needling on Spasticity in Multiple Sclerosis Evaluated Through the Rate-Dependent Depression of the H Reflex: A Case Report
por: León, Felix, et al.
Publicado: (2023)

The Broad Concept of “Spasticity-Plus Syndrome” in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms
por: Fernández, Óscar, et al.
Publicado: (2020)

Perceived Impact of Spasticity Is Associated with Spatial and Temporal Parameters of Gait in Multiple Sclerosis
por: Balantrapu, Swathi, et al.
Publicado: (2012)

Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity
por: Gajofatto, Alberto, et al.
Publicado: (2023)

Non‐interventional, prospective, observational study on spasticity‐associated symptom control with nabiximols as add‐on therapy in patients with multiple sclerosis spasticity in Austria
por: Guger, Michael, et al.
Publicado: (2023)

Novel Treatment Using Intravenous Dantrolene Sodium for Postoperative Exacerbated Spasticity in Multiple Sclerosis: A Case Report
por: Sturgill, Emily L., et al.
Publicado: (2018)

Variability of Multiple Sclerosis Spasticity Symptoms in Response to THC:CBD Oromucosal Spray: Tracking Cases through Clinical Scales and Video Recordings
por: Flachenecker, Peter, et al.
Publicado: (2018)

Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
por: Lakhan, Shaheen E, et al.
Publicado: (2009)

Arbaclofen extended-release tablets for spasticity in multiple sclerosis: randomized, controlled clinical trial
por: Okuda, Darin T, et al.
Publicado: (2022)

Arbaclofen extended-release tablets for spasticity in multiple sclerosis: open-label extension study
por: Okuda, Darin T, et al.
Publicado: (2023)

Spasticity treatment patterns among people with multiple sclerosis: a Swedish cohort study
por: Smith, Kelsi A, et al.
Publicado: (2023)

A real‐world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described ‘spasticity‐plus syndrome’
por: Patti, Francesco, et al.
Publicado: (2022)

Impact of Massage Therapy on Fatigue, Pain, and Spasticity in People with Multiple Sclerosis: a Pilot Study
por: Backus, Deborah, et al.
Publicado: (2016)

The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis‐related spasticity
por: Celius, Elisabeth G., et al.
Publicado: (2018)

Synergic use of botulinum toxin injection and radial extracorporeal shockwave therapy in Multiple Sclerosis spasticity
por: Marinaro, Cinzia, et al.
Publicado: (2021)

Transcutaneous Spinal Cord Stimulation Enhances Walking Performance and Reduces Spasticity in Individuals with Multiple Sclerosis
por: Hofstoetter, Ursula S., et al.
Publicado: (2021)

Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience
por: D’hooghe, Marie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_27gogefua6ic1m623dil9e07ns